{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:04:41Z","timestamp":1790687081837,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"DOI":"10.1007\/s40122-026-00893-0","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:52:05Z","timestamp":1790686325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Nerve Hyperexcitability: Potential Implications of Cerebrospinal Fluid CASPR2 Antibodies for Central Pain Processing in Isaacs Syndrome: A Case-Based Systematic Review"],"prefix":"10.1007","author":[{"given":"Rafaella","family":"Theologou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-3092","authenticated-orcid":false,"given":"Panagiotis","family":"Zis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"893_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/B978-0-444-64142-7.00054-0","volume":"161","author":"B Katirji","year":"2019","unstructured":"Katirji B. Peripheral nerve hyperexcitability. Handb Clin Neurol. 2019;161:281\u201390. https:\/\/doi.org\/10.1016\/B978-0-444-64142-7.00054-0.","journal-title":"Handb Clin Neurol."},{"issue":"1","key":"893_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34150","volume":"15","author":"AN Patel","year":"2023","unstructured":"Patel AN, Patel PK, Desai J, Margam SS, Oakley K, Reddy PJ. A rare phenomenon of Isaacs syndrome: a case report. Cureus. 2023;15(1):e34150. https:\/\/doi.org\/10.7759\/cureus.34150.","journal-title":"Cureus."},{"issue":"1","key":"893_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mus.24632","volume":"52","author":"A Ahmed","year":"2015","unstructured":"Ahmed A, Simmons Z. Isaacs syndrome: a review. Muscle Nerve. 2015;52(1):5\u201312. https:\/\/doi.org\/10.1002\/mus.24632.","journal-title":"Muscle Nerve."},{"issue":"4","key":"893_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/CND.0b013e318246197d","volume":"13","author":"SS Rana","year":"2012","unstructured":"Rana SS, Ramanathan RS, Small G, Adamovich B. Paraneoplastic Isaacs\u2019 syndrome: a case series and review of the literature. J Clin Neuromuscul Dis. 2012;13(4):228\u201333. https:\/\/doi.org\/10.1097\/CND.0b013e318246197d.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"2","key":"893_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/brain\/116.2.453","volume":"116","author":"J Newsom-Davis","year":"1993","unstructured":"Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs\u2019 syndrome). Report of five cases and literature review. Brain. 1993;116(2):453\u201369. https:\/\/doi.org\/10.1093\/brain\/116.2.453.","journal-title":"Brain"},{"key":"893_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/BF00900952","volume":"243","author":"M de Carvalho","year":"1996","unstructured":"de Carvalho M, Albuquerque L. Cold-induced neuromyotonia. J Neurol. 1996;243:614\u20136. https:\/\/doi.org\/10.1007\/BF00900952.","journal-title":"J Neurol"},{"issue":"4","key":"893_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.clinph.2017.01.018","volume":"128","author":"MO Santos","year":"2017","unstructured":"Santos MO, Swash M, de Carvalho M. The generator site in acquired autoimmune neuromyotonia. Clin Neurophysiol. 2017;128(4):643\u20136. https:\/\/doi.org\/10.1016\/j.clinph.2017.01.018.","journal-title":"Clin Neurophysiol"},{"key":"893_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-444-63432-0.00011-6","volume":"133","author":"SR Irani","year":"2016","unstructured":"Irani SR, Vincent A. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurol. 2016;133:185\u201397. https:\/\/doi.org\/10.1016\/B978-0-444-63432-0.00011-6.","journal-title":"Handb Clin Neurol."},{"key":"893_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2017.02.063","volume":"41","author":"J Song","year":"2017","unstructured":"Song J, Jing S, Quan C, et al. Isaacs syndrome with CASPR2 antibody: a series of three cases. J Clin Neurosci. 2017;41:63\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2017.02.063.","journal-title":"J Clin Neurosci"},{"key":"893_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577491","volume":"353","author":"V Samogalskyi","year":"2021","unstructured":"Samogalskyi V, Alcalay Y, Gadoth A, Eilam A, Gilad R. Case report: isolated muscle neuromyotonia, as presenting feature of Isaacs\u2019 syndrome. J Neuroimmunol. 2021;353:577491. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577491.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"893_CR11","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2169\/internalmedicine.9670-22","volume":"62","author":"A Murayama","year":"2023","unstructured":"Murayama A, Sugaya K, Hara M, et al. Leucine-rich glioma-inactivated 1 encephalitis followed by Isaacs syndrome: alternating presence of pathogenic autoantibodies to leucine-rich glioma-inactivated 1 and contactin-associated protein-like 2. Intern Med. 2023;62(11):1659\u201363. https:\/\/doi.org\/10.2169\/internalmedicine.9670-22.","journal-title":"Intern Med"},{"key":"893_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577569","volume":"355","author":"C Liu","year":"2021","unstructured":"Liu C, Ji S, Bi Z, Shang K, Gao H, Bu B. Tacrolimus as a therapeutic option in patients with acquired neuromyotonia. J Neuroimmunol. 2021;355:577569. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577569.","journal-title":"J Neuroimmunol"},{"issue":"10","key":"893_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jamaneurol.2013.2863","volume":"70","author":"J Fleisher","year":"2013","unstructured":"Fleisher J, Richie M, Price R, Scherer S, Dalmau J, Lancaster E. Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis. JAMA Neurol. 2013;70(10):1311\u20134. https:\/\/doi.org\/10.1001\/jamaneurol.2013.2863.","journal-title":"JAMA Neurol"},{"key":"893_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2025.578734","volume":"408","author":"S Cornacchini","year":"2025","unstructured":"Cornacchini S, Verza MU, Schiavolin M, Spagni G, Schiavo E, Lotti A, et al. Neuropathic pain in CASPR2 antibody disease spectrum: a systematic review. J Neuroimmunol. 2025;408:578734. https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578734.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"893_CR15","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jamaneurol.2018.2681","volume":"75","author":"A Vincent","year":"2018","unstructured":"Vincent A, Pettingill P, Pettingill R, Lang B, Birch R, Waters P, et al. Association of leucine-rich glioma inactivated protein 1, contactin-associated protein 2, and contactin 2 antibodies with clinical features and patient-reported pain in acquired neuromyotonia. JAMA Neurol. 2018;75(12):1519\u201327. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2681.","journal-title":"JAMA Neurol"},{"issue":"9","key":"893_CR16","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","volume":"73","author":"B Joubert","year":"2016","unstructured":"Joubert B, Saint-Martin M, Noraz N, et al. Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol. 2016;73(9):1115\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2016.1585.","journal-title":"JAMA Neurol"},{"issue":"4","key":"893_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","volume":"267","author":"M Boyko","year":"2020","unstructured":"Boyko M, Au KLK, Casault C, de Robles P, Pfeffer G. Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol. 2020;267(4):1137\u201346. https:\/\/doi.org\/10.1007\/s00415-019-09686-2.","journal-title":"J Neurol"},{"issue":"2","key":"893_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10067-016-3499-z","volume":"36","author":"F Xiao","year":"2017","unstructured":"Xiao F. Neuromyotonia as an unusual neurological complication of primary Sj\u00f6gren\u2019s syndrome: case report and literature review. Clin Rheumatol. 2017;36(2):481\u20134. https:\/\/doi.org\/10.1007\/s10067-016-3499-z.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"893_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","volume":"97","author":"JM Dawes","year":"2018","unstructured":"Dawes JM, Weir GA, Middleton SJ, Patel R, Chisholm KI, Pettingill P, et al. Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability. Neuron. 2018;97(4):806-822.e10. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.033.","journal-title":"Neuron"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00893-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-026-00893-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00893-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:52:06Z","timestamp":1790686326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-026-00893-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":19,"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1007\/s40122-026-00893-0","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Panagiotis Zis is an Editorial Board member of\n                      Pain and Therapy\n                      . Panagiotis Zis was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Rafaella Theologou has nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. No experimental interventions were performed, and all clinical information reported in this case was collected as part of routine clinical practice. This article includes a case report and a systematic review of previously published studies. No new studies involving human participants or animals, beyond the reported case, were performed by the authors. Cyprus National Bioethics Committee confirmed that no formal ethical approval was required, as the analysis was based exclusively on previously published cases that are publicly available to the scientific community.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}